Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a
Acadia Pharmaceuticals is a company dedicated to innovation in neurological and rare disease therapies. Our portfolio includes the first FDA‑approved treatments for Parkinson’s disease psychosis and Rett syndrome, and we are developing additional programs in Alzheimer’s
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our
Position Summary GSK is committed to transforming outcomes for people with cancer through innovative science, bold ambition, and strong partnerships across the healthcare ecosystem. The Clinical Development Lead (CDL) – Oncology operates at the asset level
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our